Global Down Syndrome

2018 Issue 4 of 4

Issue link: https://viewer.e-digitaledition.com/i/1080513

Contents of this Issue

Navigation

Page 5 of 31

Rep. Diana DeGette: Rep. Michael Burgess: AS ONE OF FEW MEDICAL DOCTORS IN CONGRESS, REP. MICHAEL BURGESS (R-TX) HAS BEEN A STRONG ADVOCATE FOR MEDICAL RESEARCH AND HEALTHCARE INNOVATION THROUGHOUT HIS 16 YEARS OF SERVICE. REP. DIANA DEGETTE (D-CO) HAS SERVED THE PEOPLE OF COLORADO IN THE U.S. HOUSE OF REPRESENTATIVES SINCE 1997 AND IS COMPLETING HER 11TH TERM. An Advocate for Better Health for All Americans CURRENTLY, REP. DEGETTE is chair of the House Committee on Energy & Commerce Subcommittee on Oversight and Investigations. She is among Congress' leading experts and most outspoken advocates for cutting-edge scientific research. As Co-Chair of the Congressional Diabetes Caucus, she has advanced critical appropriation funds for scientific breakthroughs that improve health outcomes for Americans living with life-altering conditions. Rep. DeGette advocates for individuals with Down syndrome and serves on the Congressional Task Force on Down Syndrome. On multiple occasions, she has served as an Honorary Chair for the Global Down Syndrome Foundation's Be Beautiful Be Yourself Fashion Show, the largest fundraiser for Down syndrome in the world. She also recently received the Civil Rights Award from the 2018 NEWSED Community Development Corporation. Rep. DeGette is committed to continuing to promote the rights and interests of those with Down syndrome. As a member of the Energy & Commerce Subcommittee, she was the lead co-sponsor of the 21st Century Cures Act. Her bipartisan work and leadership on the passage of this law has led to updates in our laws governing health research to keep pace with medical innovation. Her work has ensured that the United States is equipped to effectively address the most complex challenges in modern medicine. REP. BURGESS was elected to the U.S. House of Representatives in 2002 and took office in 2003. He is a member of the House Committee on Energy & Commerce Subcommittees on Health, Consumer Protection & Commerce, and Oversight and Investigations. Burgess was a key supporter and featured organizer of the September 2018 congressional briefing that focused on the relationship between Down syndrome and cancer. As a member of the Congressional Task Force on Down Syndrome, he is a champion for research, medical care, quality of life, and other important issues for people with Down syndrome and their families. In 2016, Rep. Burgess was a leader in the effort to pass the 21st Century Cures Act, which increased the budget at the National Institutes of Health (NIH) by $8.75 billion over five years. Many of the new initiatives under the 21st Century Cures Act are designed to advance the field of precision medicine and potentially fuel discoveries for curing cancer, mental health disorders, and other critical areas. In a hearing celebrating the one-year anniversary of the 21st Century Cures Act, Rep. Burgess encouraged the NIH to continue trans-NIH initiatives and highlighted research for individuals with three copies of chromosome 21, which occurs in Down syndrome. He emphasized the need for a trans-NIH initiative around Down syndrome, as people with Down syndrome are highly protected from most cancers and heart attack but highly predisposed to Alzheimer's disease, childhood leukemia, and certain autoimmune disorders. Fighting for Important Medical Care Research 2018 ISSUE 4 OF 4 • DOWN SYNDROME WORLD ™ 6

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - 2018 Issue 4 of 4